Pre-Exposure Prophylaxis (PrEP)

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GS
Gilead SciencesFOSTER CITY, CA
2 programs
PrEP-RNN/A1 trial
PrEP-RNN/A
Active Trials
NCT05095818Completed440Est. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Gilead SciencesPrEP-RN

Clinical Trials (1)

Total enrollment: 440 patients across 1 trials

NCT05095818Gilead SciencesPrEP-RN

Impact of Nursing Involvement on Implementation of HIV Prevention Services

Start: Apr 2021Est. completion: Mar 2022440 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space